The Radiopharmaceutical Injectors Market, valued at USD 27.8 million in 2023, is projected to reach USD 52.3 million by 2032, growing at a CAGR of 7.2%. Rising prevalence of cancer, cardiovascular diseases, and technological advancements in PET & SPECT imaging are driving market growth.